Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
Pernette R. W. de Sauvage Nolting(Amsterdam UMC Location University of Amsterdam), John J.P. Kastelein(QRx Pharma (United States)), Mieke D. Trip(Amsterdam UMC Location University of Amsterdam), Aeilko H. Zwinderman(Amsterdam Neuroscience), Rudolf J.A Buirma, Eric de Groot(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 87
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k